融合-话题@MedSci

#融合#

253篇内容 | 4121人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1525514, encodeId=fd36152551462, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=J Endod：对上颌**和第二磨牙牙根融合伴随合并及C型根管结构的分析, objectType=article, longId=177432, objectId=35dc1e743204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35dc1e743204, replyNumber=0, likeNumber=33, createdTime=2019-08-12, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35dc1e743204, moduleTitle=J Endod：对上颌**和第二磨牙牙根融合伴随合并及C型根管结构的分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35dc1e743204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525513, encodeId=c949152551347, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=美国国家医学院院长称：制服高血压有赖于数据、生物技术和生物医学科学融合, objectType=article, longId=177330, objectId=e8461e733060, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8461e733060, replyNumber=0, likeNumber=60, createdTime=2019-08-11, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8461e733060, moduleTitle=美国国家医学院院长称：制服高血压有赖于数据、生物技术和生物医学科学融合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8461e733060)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525512, encodeId=032715255123c, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=加拿大卫生部批准VITRAKVI®（larotrectinib）治疗NTRK基因融合的晚期实体瘤, objectType=article, longId=176548, objectId=f7e11e654865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7e11e654865, replyNumber=0, likeNumber=59, createdTime=2019-08-01, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7e11e654865, moduleTitle=加拿大卫生部批准VITRAKVI®（larotrectinib）治疗NTRK基因融合的晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7e11e654865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525511, encodeId=49cf152551156, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=EMA建议批准Vitrakvi治疗NTRK基因融合的实体瘤患者, objectType=article, longId=176376, objectId=d5511e6376a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5511e6376a5, replyNumber=0, likeNumber=73, createdTime=2019-07-30, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5511e6376a5, moduleTitle=EMA建议批准Vitrakvi治疗NTRK基因融合的实体瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5511e6376a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525510, encodeId=54ed152551059, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=JCLA：重组链霉亲和蛋白融合蛋白作为快速检测丙型肝炎病毒感染的信号转导蛋白, objectType=article, longId=175573, objectId=336b1e5573a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=336b1e5573a7, replyNumber=0, likeNumber=65, createdTime=2019-07-17, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=336b1e5573a7, moduleTitle=JCLA：重组链霉亲和蛋白融合蛋白作为快速检测丙型肝炎病毒感染的信号转导蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=336b1e5573a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525509, encodeId=b2a4152550921, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=泛癌种靶向药在日本获批用于治疗NTRK基因融合晚期复发实体瘤, objectType=article, longId=168843, objectId=cbc71688433a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbc71688433a, replyNumber=0, likeNumber=66, createdTime=2019-06-22, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbc71688433a, moduleTitle=泛癌种靶向药在日本获批用于治疗NTRK基因融合晚期复发实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbc71688433a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525508, encodeId=f91f152550888, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=ASCO2019 |新型融合抗PD-L1抗体试用在中国晚期实体瘤患者中的应用, objectType=article, longId=167544, objectId=773f16e5442b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=773f16e5442b, replyNumber=0, likeNumber=85, createdTime=2019-06-04, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=773f16e5442b, moduleTitle=ASCO2019 |新型融合抗PD-L1抗体试用在中国晚期实体瘤患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=773f16e5442b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525507, encodeId=afd2152550e3b, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=J Orthop Surg：唑来膦酸静脉应用于颈椎前路椎间盘切除融合术后颈椎病和骨质疏松症的临床疗效观察, objectType=article, longId=166865, objectId=5cb516686565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cb516686565, replyNumber=0, likeNumber=60, createdTime=2019-05-28, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cb516686565, moduleTitle=J Orthop Surg：唑来膦酸静脉应用于颈椎前路椎间盘切除融合术后颈椎病和骨质疏松症的临床疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cb516686565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525506, encodeId=1f131525506fe, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Adv Sci：基于石墨烯的微小RNA转染阻断前破骨细胞融合以增加骨形成和血管形成, objectType=article, longId=166222, objectId=4d4c166222a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d4c166222a4, replyNumber=0, likeNumber=132, createdTime=2019-05-18, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d4c166222a4, moduleTitle=Adv Sci：基于石墨烯的微小RNA转染阻断前破骨细胞融合以增加骨形成和血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d4c166222a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525505, encodeId=0b1d152550552, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=多模态影像融合神经导航在脑动静脉畸形手术的应用, objectType=article, longId=166134, objectId=79cc166134f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79cc166134f3, replyNumber=0, likeNumber=73, createdTime=2019-05-16, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79cc166134f3, moduleTitle=多模态影像融合神经导航在脑动静脉畸形手术的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79cc166134f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525504, encodeId=3aba1525504e6, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=III期临床试验证实Fc融合凝血因子延长半衰期，可为血友病患者提供有效的围手术期止血, objectType=article, longId=165917, objectId=84ae16591e2f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84ae16591e2f, replyNumber=0, likeNumber=72, createdTime=2019-05-14, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84ae16591e2f, moduleTitle=III期临床试验证实Fc融合凝血因子延长半衰期，可为血友病患者提供有效的围手术期止血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84ae16591e2f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525503, encodeId=8e061525503c6, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=陆道培医学团队于国际学术期刊报道白血病新融合基因, objectType=article, longId=165002, objectId=273e1650027d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=273e1650027d, replyNumber=0, likeNumber=67, createdTime=2019-04-27, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=273e1650027d, moduleTitle=陆道培医学团队于国际学术期刊报道白血病新融合基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=273e1650027d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525502, encodeId=72131525502a8, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=拜耳公布larotrectinib治疗NTRK基因融合阳性转移性非小细胞肺癌患者的亚组分析结果, objectType=article, longId=164175, objectId=36571641e5d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36571641e5d2, replyNumber=0, likeNumber=94, createdTime=2019-04-14, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36571641e5d2, moduleTitle=拜耳公布larotrectinib治疗NTRK基因融合阳性转移性非小细胞肺癌患者的亚组分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36571641e5d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525501, encodeId=ddd015255018d, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=腰椎融合+PVP术中骨水泥渗漏粘附于下腔静脉滤器1例, objectType=article, longId=163894, objectId=c5bf163894b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5bf163894b8, replyNumber=0, likeNumber=71, createdTime=2019-04-10, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5bf163894b8, moduleTitle=腰椎融合+PVP术中骨水泥渗漏粘附于下腔静脉滤器1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5bf163894b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525500, encodeId=f834152550041, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=DIABETOLOGIA：MEDI4166，PCSK9抗体和GLP-1类似物融合分子在2型糖尿病超重或肥胖患者中研究, objectType=article, longId=163568, objectId=c531163568f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c531163568f7, replyNumber=0, likeNumber=62, createdTime=2019-04-05, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c531163568f7, moduleTitle=DIABETOLOGIA：MEDI4166，PCSK9抗体和GLP-1类似物融合分子在2型糖尿病超重或肥胖患者中研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c531163568f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525499, encodeId=72c1152549976, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Eur Radiol：融合瘤周影像特征的影像组学建模新思路, objectType=article, longId=163171, objectId=bde61631e199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bde61631e199, replyNumber=0, likeNumber=81, createdTime=2019-03-30, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bde61631e199, moduleTitle=Eur Radiol：融合瘤周影像特征的影像组学建模新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bde61631e199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525498, encodeId=8ef8152549804, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Prostate Cancer P D：MRI-US融合前列腺活检学习曲线鉴定分析, objectType=article, longId=162606, objectId=9c54162606a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c54162606a4, replyNumber=0, likeNumber=64, createdTime=2019-03-20, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c54162606a4, moduleTitle=Prostate Cancer P D：MRI-US融合前列腺活检学习曲线鉴定分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c54162606a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525497, encodeId=73a4152549e3c, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Biotechnol Rep：植物来源的重组骨桥蛋白-Fc融合蛋白可增强骨生成, objectType=article, longId=162053, objectId=1ece162053a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ece162053a6, replyNumber=0, likeNumber=61, createdTime=2019-03-12, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ece162053a6, moduleTitle=Biotechnol Rep：植物来源的重组骨桥蛋白-Fc融合蛋白可增强骨生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ece162053a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525496, encodeId=d7e01525496f3, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=SCIENCE：流感病毒的小分子融合抑制剂具有口服活性, objectType=article, longId=162007, objectId=517216200e65, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=517216200e65, replyNumber=0, likeNumber=76, createdTime=2019-03-12, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=517216200e65, moduleTitle=SCIENCE：流感病毒的小分子融合抑制剂具有口服活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=517216200e65)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525495, encodeId=e921152549575, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=反转！医生被患者打伤后仍为其治疗，人民日报：无助于医患关系融合, objectType=article, longId=161150, objectId=bbaf161150b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbaf161150b3, replyNumber=0, likeNumber=63, createdTime=2019-02-27, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbaf161150b3, moduleTitle=反转！医生被患者打伤后仍为其治疗，人民日报：无助于医患关系融合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbaf161150b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

融合

2020-05-29

licz0427 (审核中...)

前往app查看评论内容

#融合#

J Endod：对上颌**和第二磨牙牙根融合伴随合并及C型根管结构的分析

2019-08-12

licz0427 (审核中...)

前往app查看评论内容

#融合#

美国国家医学院院长称：制服高血压有赖于数据、生物技术和生物医学科学融合

2019-08-11

licz0427 (审核中...)

前往app查看评论内容

#融合#

加拿大卫生部批准VITRAKVI®（larotrectinib）治疗NTRK基因融合的晚期实体瘤

2019-08-01

licz0427 (审核中...)

前往app查看评论内容

#融合#

EMA建议批准Vitrakvi治疗NTRK基因融合的实体瘤患者

2019-07-30

licz0427 (审核中...)

前往app查看评论内容

#融合#

JCLA：重组链霉亲和蛋白融合蛋白作为快速检测丙型肝炎病毒感染的信号转导蛋白

2019-07-17

licz0427 (审核中...)

前往app查看评论内容

#融合#

泛癌种靶向药在日本获批用于治疗NTRK基因融合晚期复发实体瘤

2019-06-22

licz0427 (审核中...)

前往app查看评论内容

#融合#

ASCO2019 |新型融合抗PD-L1抗体试用在中国晚期实体瘤患者中的应用

2019-06-04

licz0427 (审核中...)

前往app查看评论内容

#融合#

J Orthop Surg：唑来膦酸静脉应用于颈椎前路椎间盘切除融合术后颈椎病和骨质疏松症的临床疗效观察

2019-05-28

licz0427 (审核中...)

前往app查看评论内容

#融合#

Adv Sci：基于石墨烯的微小RNA转染阻断前破骨细胞融合以增加骨形成和血管形成

2019-05-18

licz0427 (审核中...)

前往app查看评论内容

#融合#

多模态影像融合神经导航在脑动静脉畸形手术的应用

2019-05-16

licz0427 (审核中...)

前往app查看评论内容

#融合#

III期临床试验证实Fc融合凝血因子延长半衰期，可为血友病患者提供有效的围手术期止血

2019-05-14

licz0427 (审核中...)

前往app查看评论内容

#融合#

陆道培医学团队于国际学术期刊报道白血病新融合基因

2019-04-27

licz0427 (审核中...)

前往app查看评论内容

#融合#

拜耳公布larotrectinib治疗NTRK基因融合阳性转移性非小细胞肺癌患者的亚组分析结果

2019-04-14

licz0427 (审核中...)

前往app查看评论内容

#融合#

腰椎融合+PVP术中骨水泥渗漏粘附于下腔静脉滤器1例

2019-04-10

licz0427 (审核中...)

前往app查看评论内容

#融合#

DIABETOLOGIA：MEDI4166，PCSK9抗体和GLP-1类似物融合分子在2型糖尿病超重或肥胖患者中研究

2019-04-05

licz0427 (审核中...)

前往app查看评论内容

#融合#

Eur Radiol：融合瘤周影像特征的影像组学建模新思路

2019-03-30

licz0427 (审核中...)

前往app查看评论内容

#融合#

Prostate Cancer P D：MRI-US融合前列腺活检学习曲线鉴定分析

2019-03-20

licz0427 (审核中...)

前往app查看评论内容

#融合#

Biotechnol Rep：植物来源的重组骨桥蛋白-Fc融合蛋白可增强骨生成

2019-03-12

licz0427 (审核中...)

前往app查看评论内容

#融合#

SCIENCE：流感病毒的小分子融合抑制剂具有口服活性

2019-03-12

licz0427 (审核中...)

前往app查看评论内容

#融合#

反转！医生被患者打伤后仍为其治疗，人民日报：无助于医患关系融合

2019-02-27

科室
- - 订阅+
  - 更多科室
工具
服务